fosamprenavir has been researched along with dolutegravir in 1 studies
Studies (fosamprenavir) | Trials (fosamprenavir) | Recent Studies (post-2010) (fosamprenavir) | Studies (dolutegravir) | Trials (dolutegravir) | Recent Studies (post-2010) (dolutegravir) |
---|---|---|---|---|---|
174 | 55 | 37 | 1,128 | 179 | 1,105 |
Protein | Taxonomy | fosamprenavir (IC50) | dolutegravir (IC50) |
---|---|---|---|
Chain A, PFV integrase | Human spumaretrovirus | 0.0517 | |
Chain A, PFV integrase | Human spumaretrovirus | 0.0517 | |
Chain A, PFV integrase | Human spumaretrovirus | 0.0517 | |
Solute carrier family 22 member 2 | Homo sapiens (human) | 1.9 | |
Integrase | Human immunodeficiency virus 1 | 0.0414 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borland, J; Chen, S; Peppercorn, A; Piscitelli, SC; Song, I; Wajima, T | 1 |
1 trial(s) available for fosamprenavir and dolutegravir
Article | Year |
---|---|
Effect of fosamprenavir-ritonavir on the pharmacokinetics of dolutegravir in healthy subjects.
Topics: Adult; Area Under Curve; Carbamates; Drug Administration Schedule; Drug Interactions; Female; Furans; Healthy Volunteers; Heterocyclic Compounds, 3-Ring; HIV Integrase; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Male; Organophosphates; Oxazines; Piperazines; Pyridones; Ritonavir; Sulfonamides | 2014 |